By 2033, the global oral clinical nutrition supplement market is expected to reach USD 19613.1 million, surpassing USD 10788.70 million in 2023. A CAGR of 6.2% indicates positive market growth over the forecast period.
The rising demand for oral clinical supplements is attributable to a higher focus on maintaining strong immunity. The demand in the oral clinical nutrition supplement market is poised to surge. Its applications in tackling the issue of malnutrition may aid the overall growth of the oral clinical nutrition supplement market.
Several oral clinical nutrition supplement manufacturers are introducing new flavors to attract a more consumer base. This may remain one of the key factors spurring growth in the market.
A patient suffering from a prolonged infection or half-starved for nutritional improvement can benefit from oral clinical nutrition supplements. Also, oral clinical nutrition supplements can be used by patients who lose interest in eating normal food due to a loss of taste due to prolonged infection.
Among the key factors expected to drive the growth of the oral clinical nutrition supplements market are the growing number of young people and the higher demand for healthy food, as well as the growing demand for varied oral clinical nutrition supplements among the majority of the population.
In addition, global players in the food processing industry are expected to grow and attend more, chronic infections are on the rise, and healthcare costs are on the rise. In addition, oral clinical nutrition supplements are expected to be in high demand due to increasing healthcare costs.
Oral clinical nutrition supplement sales are expected to grow along with the growing geriatric and aging populations shortly. These populations are among the other factors driving the market.
Although there is potential for growth in the global oral clinical nutrition supplements market, high costs and regulatory compliance could limit it. Raw material prices may also hinder growth revenue to some extent because they are constantly changing.
| Attributes | Details |
|---|---|
| Oral Clinical Nutrition Supplement Market Value (2023) | USD 10788.70 million |
| Oral Clinical Nutrition Supplement Market Expected Value (2033) | USD 19613.1 million |
| Oral Clinical Nutrition Supplement Market Projected CAGR (2023 to 2033) | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Food and Drug Administration (FDA) has narrowly restricted illegal claims on diseases and health maintenance provided by the oral clinical nutrition supplement manufacturers on their products. Manufacturers who want to sell their oral clinical nutrition supplements with disease claims must get them approved by FDA.
According to FMI’s analysis, oral clinical nutrition supplement sales have grown at a CAGR of more than 5.0% between 2017 and 2022. The rising interest of consumers in oral clinical nutrition supplements is providing impetus to the growth registered.
This has also encouraged manufacturers to participate in research and development (R&D) activities. Some scientists are investigating whether increasing the quality of certain nutrients, such as vitamin C and vitamin E, with food additives such as probiotics or beyond the Prescribed Dietary Allowances (RDA), could improve bone health, especially in the elderly.
This will also help the market is gaining traction. FMI projects that global oral clinical nutrition supplements grow at a CAGR of around 6.2% through 2033.
Short Term (2022 to 2025): The short-term growth prospects of the market are likely to grow as there could be increased research and development of new oral clinical nutrition supplements, particularly those that are tailored to the needs of specific patient populations or medical conditions.
Medium Term (2025 to 2028): The market is likely to show a slight uptake as it could be increased awareness and adoption of these supplements among healthcare professionals and patients.
Long Term (2028 to 2033): The long-term goal for the oral clinical nutrition supplement market could involve collaborations between pharmaceutical companies, healthcare providers, and academic researchers to identify gaps in the market and develop innovative new products to fill those gaps.
| Historical CAGR | 5.0% |
|---|---|
| Historical Market Value (2022) | USD 10157.10 million |
| Forecast CAGR | 6.2% |
Malnutrition Continue Spurring Oral Nutrition Supplements Sales
An article, titled “Ready to use Therapeutic Food [RUTF] formulation and packaging for malnutrition: an Overview” highlighted how nutritional supplements are helping to tackle the issue of malnutrition.
Malnutrition is a universal challenge faced by several people around the world. Less than 45% of patients classified as malnourished receive adequate medical intervention around the globe.
Malnutrition leads consumers to several consequences such as apathy, reduced muscle strength, impaired immune response, inactivity, impaired wound healing and fatigue, depression, and self-neglect which is leading consumers to poor quality of life.
Therefore, proper nutritional treatment planning has now become crucial to fight against malnutrition and such nutritional assistance can be offered by an oral nutritional supplement. In a broad variety of patient groups, oral dietary supplements have demonstrated practical, nutritional, clinical, and economic advantages, both in community areas and in hospitals.
Treatment of patients with high-protein oral nutritional supplements has shown that total readmissions have decreased by 30%, which has resulted in a rise in demand for oral nutritional supplements.
Moreover, increasing evidence of the effectiveness of oral clinical nutrition supplements in the fight against malnutrition is expected to result in an increased demand for oral nutrition supplements over the forecast period.
Oral Clinical Nutrition Supplement Launched in a Variety of Flavors and Forms
Oral nutritional supplements are usually prescribed to patients suffering from any chronic illness or malnutrition to improve their health conditions. It has been found that patients appear to lose interest in eating typical food products during some medical conditions when they suffer a lack of taste.
To tackle this situation oral clinical nutrition supplement manufacturers are launching products in several forms and flavors. Innovative flavors and forms had a significant impact on consumers, primarily the millennial generation as they are very curious to try out new things.
This is a key trend influencing product launches over the last few years. For instance, in 2019 PRO-DIPTM launched oral nutrition supplements, in what it calls a revolutionary pouch. Originally intended to be a smokeless tobacco, PRO-DIP packed a burst of vitamins and natural energy supplements in small and semi-permeable sachets.
Principal Consultant
FMI estimates that in the product type segment standard formula oral clinical nutrition supplements are holding more than 60% of the market share with a CAGR of 6.2%.
The standard formula is consumed for several types of diseases/indications while specialized formula is specially developed to treat a patient suffering from a particular disease or a specific condition. This has resulted in higher consumption of the standard formula.
Oral nutrition supplements are often taken for general well-being, catapulting it as the leading segment within the market in terms of indication. General well-being is projected to remain dominant through the course of the forecast period. It is likely to account for nearly 20% of sales registered.
Increasing focus on maintaining good health and immune systems among consumers will seal dominance of this segment through the forecast period.
The geriatric population has emerged as the leading end user of oral clinical nutrition. The geriatric population segment may account for over 40% of sales through the forecast period.
Low immunity in aged people can trigger various health issues. This makes the geriatric population, key end users of oral clinical nutrition supplements.
Liquid-form oral clinical nutrition supplements currently account for a dominant 40% of the market and are expected to remain the leading segment in terms of form through the forecast period. Increasing the launch of oral clinical nutrition formulas in liquid form may continue aiding growth in this segment with a CAGR of 7.2%
Flavored oral clinical nutrition supplements currently hold more than 70% market share. In the flavored segment, chocolate-flavored oral clinical nutrition supplements are highly sought-after.
Prescription-based channels are responsible for more than 90% of sales of oral clinical nutrition supplements around the world. Oral clinical nutrition supplements are often administered as per the dosage prescribed by doctors. This is expected to aid expansion within the sales channel.
| Region | North America |
|---|---|
| Country | United States |
| Historic CAGR | 7.3% |
| Forecasted CAGR | 8.8% |
| Absolute Dollar Growth | USD 3282 million |
| Market Value (2033) | USD 5797.2 million |
| Region | Europe |
|---|---|
| Country | Germany |
| Historic CAGR | 5.3% |
| Forecasted CAGR | 7.0% |
| Absolute Dollar Growth | USD 329.8 million |
| Market Value (2033) | USD 912.1 million |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| Historic CAGR | 5.8% |
| Forecasted CAGR | 6.7% |
| Absolute Dollar Growth | USD 389.4 million |
| Market Value (2033) | USD 822.1 million |
| Region | Europe |
|---|---|
| Country | Spain |
| Historic CAGR | 5.1% |
| Forecasted CAGR | 7.2% |
| Absolute Dollar Growth | USD 309.2 million |
| Market Value (2033) | USD 619.3 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| Historic CAGR | 3.4% |
| Forecasted CAGR | 4.2% |
| Absolute Dollar Growth | USD 1242.60 million |
| Market Value (2033) | USD 3771.9 million |
The United States is one of the leading markets for oral clinical nutrition supplements. One of the key factors behind the growth of demand for oral clinical nutrition supplements is the increasing number of consumers having immunity deficiency.
According to WebMD, nearly 3% of adults in the United States have weakened immunity. The prevalence of immunosuppression is rising in the country. This reflects a higher risk for autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and lupus.
Against this backdrop, the sales of oral clinical nutrition are expected to remain considerably high. With the demand for non-invasive treatment methods rising, the United States is expected to remain a key market within North America.
It is expected to account for more than 25% of global sales of oral clinical nutrition supplements in the year 2023 and remains dominant through the forecast period.
China is one of the primary pockets for oral clinical nutrition supplement sales. It is expected to account for around 20% market share of the global oral clinical supplements market.
The large patient population base coupled with an increase in incidences of chronic diseases provides lucrative growth opportunities for Oral Clinical Nutrition Supplement companies to record high sales in these markets.
For example, the International Network for Cancer Treatment and Research stated that the burden of cancer in developing regions such as Asia Pacific is increasing rapidly, particularly in countries such as India and China.
China also is one of the most populated countries in the world, having a large patient pool affected with various chronic diseases. This would, in turn, increase the demand for oral clinical nutrition supplements.
GCC countries are among the key markets in MEA for oral clinical nutrition supplements. GCC countries are responsible for more than 80% of sales of oral clinical nutrition supplements in MEA and they are expected to grow at a CAGR of more than 2.0% in the forecast period.
Brazil is dominating the oral clinical nutrition supplement market in Latin America. It accounted for more than 40.0% of sales of oral clinical nutrition supplements in the region and is expected to grow at a high positive CAGR over the forecast period.
The key factor in rising sales in Brazil is the increasing focus on health and wellness. Thus, to boost the immunity system and also to maintain digestive health these consumers are seeking oral clinical nutrition supplements.
Russia is one of the leading markets for oral clinical nutrition supplements in Europe. It accounted for more than 10% of sales in the region and is expected to grow at a CAGR of more than 4.5% over the forecast period.
The prevalence of malnutrition and various autoimmune diseases will continue to support expansion in the country.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players in the oral clinical nutrition supplement market are:
Recent Development
The key players are mainly focusing on strategies that may help them increase their market share and gain a competitive advantage.
For instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; The Middle East and Africa; East Asia |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UNITED KINGDOM, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey |
| Key Segments Covered | Product, Indication, Form, End User, Flavor, Channel, Region |
| Key Companies Profiled | NUTRICIÓN MÉDICA SL; Meiji Holdings Co., Ltd.; Medtrition Inc.; Baxter International Inc.; B. Braun Melsungen AG.; Fresenius Kabi AG; Mead Johnson & Company, LLC; Otsuka Holdings Co., Ltd.; Abbott Laboratories; Danone Nutricia; Victus, Inc.; Cambrooke Therapeutics, Inc.; GlaxoSmithKline plc; Nestlé S.A.; Kate Farms, Inc.; Perrigo Company plc; Sichuan Kelun Pharmaceutical Co., Ltd.; AYMES International Ltd.; Pfizer Inc.; Medifood GmbH; Nature’s Bounty Inc.; Pharmavite LLC.; Bayer AG; Church & Dwight Co. Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The caustic lye segment accounts for nearly 68% of the global market.
The market is estimated to accrue around USD 10,788.7 million revenue in 2023.
The United States leads with a forecasted CAGR of 8.8% through 2033.
The regional market of China is poised to exhibit a 4.2% CAGR through 2033.
The overall market witnessed a growth rate of 5% from 2017 to 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Standard Formula 5.2. Specialized Formula 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. General Well-being 6.2. Renal Disorders 6.3. Hepatic Disorders 6.4. Oncology Nutrition 6.5. Diabetes 6.6. Dysphagia 6.7. IBD & GI Tract Disorders 6.8. Neurological Disorders 6.9. Respiratory Disorders 6.10. Other Indications 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form 7.1. Liquid 7.2. Semi-solid 7.3. Powder 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Adult 8.2. Geriatric 8.3. Pediatric 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Flavor 9.1. Regular 9.2. Flavored 9.2.1. Chocolate 9.2.2. Vanilla 9.2.3. Strawberry 9.2.4. Apple 9.2.5. Mixed Berries 9.2.6. Orange 9.2.7. Nut Flavors 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sales Channel 10.1. Prescription-based 10.2. Over-the-Counter 10.2.1. Modern Trade 10.2.2. Hospital Pharmacies 10.2.3. Retail Pharmacies 10.2.4. Drug Stores 10.2.5. Online Pharmacies 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia 11.6. Oceania 11.7. Middle East and Africa 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 19. Key Countries Market Analysis 20. Market Structure Analysis 21. Competition Analysis 21.1. Danone Nutricia 21.2. NUTRICIÓN MÉDICA SL 21.3. Nature’s Bounty 21.4. Medifood International 21.5. Meiji Holdings Co., Ltd. 21.6. Medtrition Inc. 21.7. GlaxoSmithKline plc 21.8. B Braun 21.9. Perrigo Nutritions 21.10. Fresenius Kabi Ltd. 21.11. Victus Inc. 21.12. Nestlé Health Science 21.13. Pharmavite LLC 21.14. Pfizer Inc. 21.15. Bayer AG 21.16. Church & Dwight Co., Inc. 22. Assumptions & Acronyms Used 23. Research Methodology
Explore Food and Beverage Insights
View Reports
Oral Clinical Nutrition Supplement Market
